Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

AI-designed drug shows early promise for lung fibrosis patients in clinical trial

Researchers report that rentosertib, an AI-discovered TNIK inhibitor, showed promising safety and potential to improve lung function in patients with idiopathic pulmonary fibrosis in a 12-week phase 2a clinical trial. The highest dose group demonstrated a trend toward increased forced vital capacity, especially among patients not receiving standard antifibrotic therapy, supporting further clinical investigation.

4 Jun 2025

Researchers warn of bird flu survival in raw milk

The stability of H5N1 in unpasteurized milk poses potential health risks. Study findings emphasize the need for awareness among consumers and dairy workers.

4 Jun 2025

An Arm and a Leg: A mathematical solution for US hospitals?

What do the KGB and the former CEO of Cincinnati Children’s Hospital have in common?

4 Jun 2025

Individual immune variation shapes the evolution of influenza strains

A new study has shown that person-to-person variation in antibody immunity plays a key role in shaping which influenza (flu) strains dominate in a population.

3 Jun 2025

Real world data confirms effectiveness of nirsevimab in young infants with bronchiolitis

A single dose of the long-acting antibody nirsevimab developed to prevent respiratory syncytial virus infections (The drug has been approved at the European level to protect infants in their first season of exposure to the virus) to infants can halve hospitalizations for bronchiolitis.

3 Jun 2025

Study: New mRNA vaccine is more scalable and adaptable to continuously evolving viruses

A new type of mRNA vaccine is more scalable and adaptable to continuously evolving viruses such as SARS-CoV-2 and H5N1, according to a study by researchers at University of Pittsburgh School of Public Health and the Pennsylvania State University.

3 Jun 2025

Engineered viruses and gene therapy halt tumor growth and extend survival in mice

This study reveals the potential of engineered phage-IL-12 therapy in melanoma, enhancing immune response and tumor destruction in aggressive cancer models.

2 Jun 2025

Molecular stress makes old neurons vulnerable to neurodegenerative diseases

As the global population ages, the risk of developing neurodegenerative diseases such as dementia, Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis (ALS) continues to rise. But the molecular mechanisms behind the deterioration of brain cells have remained elusive.

2 Jun 2025

Expert review reveals how to fuel triathletes for optimal results

This systematic review synthesizes evidence from 35 studies to guide optimal nutrition, supplementation, and recovery for triathletes. The findings highlight the critical importance of glycogen balance, hydration, targeted supplementation, and ongoing education—especially for female athletes at risk of energy deficiency.

2 Jun 2025

WHO releases first-ever position paper on immunization products to protect infants against RSV

Today, the World Health Organization (WHO) published its first-ever position paper on immunization products to protect infants against respiratory syncytial virus (RSV) – the leading cause of acute lower respiratory infections in children globally.

30 May 2025

American doctors are moving to Canada to escape the Trump administration

Earlier this year, as President Donald Trump was beginning to reshape the American government, Michael, an emergency room doctor who was born, raised, and trained in the United States, packed up his family and got out.

30 May 2025

TTF1 identified as key biomarker for advanced KRAS G12C-mutated non-small cell lung cancer

Researchers from The University of Texas MD Anderson Cancer Center have identified a new biomarker, TTF-1, that was predictive of survival outcomes for patients with advanced KRAS G12C-mutated non-small cell lung cancer (NSCLC), following treatment with the KRAS targeted therapy sotorasib.

30 May 2025

New plant-derived therapy shows promise for cancer pain relief

RTX is a non-addictive pain therapy derived from a cactus-like plant.

29 May 2025

Tree cover helps keep dengue-carrying mosquitoes at bay

Protecting trees might not seem like a public health strategy, but new research suggests it could be-especially in the tropics.

28 May 2025

Long-term cardiorespiratory effects of wildfire smoke exposure revealed

Being exposed to lingering fine particulate matter (PM2.5) from wildfire smoke can have health effects up to three months afterwards, well beyond the couple of days that previous studies have identified, and the exposure can occur even after the fires have ended.

28 May 2025

Yeast cells offer promising alternative for manufacturing DNase1

The protein DNase1 is one of the oldest biological agents in history: It has been on the market since 1958 and is now used, among other things, to treat cystic fibrosis.

28 May 2025

Sodium intake varies across racial and ethnic groups in the U.S.

Almost all adults in the U.S. consume more sodium (salt) than recommended, yet the sources and use of sodium vary among people of different races and ethnicities, indicating the need for culturally customized advice about sodium intake, according to new research published today in the Journal of the American Heart Association, an open access, peer-reviewed journal of the American Heart Association.

28 May 2025

Scientists reveal how RNA could have replicated on early earth

Chemists at UCL and the MRC Laboratory of Molecular Biology have demonstrated how RNA (ribonucleic acid) might have replicated itself on early Earth – a key process in the origin of life.

28 May 2025

Single measles strain triggers outbreak in Milan despite high vaccination rates

A unique measles B3 lineage drove a sustained local outbreak in Milan and surrounding areas in early 2025, marking a shift from previous D8 importations. This primarily affected unvaccinated adults, raising alarms about potential endemic measles resurgence in northern Italy despite high overall vaccination coverage.

27 May 2025